Arbutus Biopharma Corp
ABUS | NASDAQ
$5
-$0.01 (-0.20%)
At close: Sep 21, 2026, 4:00 PM ET
$5.04
+$0.04 (+0.90%)
Pre-market:
Sep 22, 2026, 8:17 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.01M | 179.13M | 1.05M | 529K | 10.74M | 1.76M | 1.57M | 1.34M | 1.73M | 1.53M | 2.15M | 4.66M | 4.65M | 6.69M | 6.25M | 5.95M | 14.24M | 12.58M | 3.21M | 3.34M | 2.33M | 2.11M |
Cost of Revenue | n/a | 11K | 11K | 11K | n/a | 8.96M | 8.81M | n/a | n/a | n/a | 17.56M | n/a | n/a | n/a | 22.95M | n/a | n/a | n/a | 19.21M | n/a | 15.8M | 13.78M |
Gross Profit | 1.01M | 179.12M | 1.04M | 518K | 10.74M | -7.2M | -7.24M | 1.34M | 1.73M | 1.53M | -15.42M | 4.66M | 4.65M | 6.69M | -16.7M | 5.95M | 14.24M | 12.58M | -16.01M | 3.34M | -13.47M | -11.67M |
Operating Income | -5.96M | 169.12M | -7.64M | -8.29M | 1.49M | -34.66M | -13.93M | -21.44M | -21.58M | -19.36M | -20.75M | -21.56M | -18.39M | -17.41M | -22.56M | -17.81M | -14.11M | -10.97M | -20.8M | -18.41M | -18.64M | -15.68M |
Interest Income | 842K | 815K | 877K | 952K | 1.04M | 1.2M | 1.46M | 1.75M | 1.83M | 1.55M | 1.47M | 1.49M | 1.46M | 1.27M | 943K | 694K | 396K | 159K | 30K | 27K | 31K | 39K |
Pretax Income | -5.14M | 169.7M | -3.76M | -7.74M | 2.52M | -24.53M | -12.53M | -19.72M | -19.8M | -17.88M | -19.31M | -20.1M | -17.09M | -16.34M | -21.93M | -17.57M | -14.19M | -11.32M | -21.32M | -19.16M | -19.39M | -16.38M |
Net Income | -5.14M | 169.7M | -3.76M | -7.74M | 2.52M | -24.53M | -12.53M | -19.72M | -19.8M | -17.88M | -19.31M | -20.1M | -17.09M | -16.34M | -21.93M | -17.57M | -14.19M | -15.77M | -21.32M | -19.16M | -19.39M | -16.38M |
Selling & General & Admin | 3.87M | 5.88M | 3.7M | 3.03M | 3.33M | 5.83M | 8.43M | 4.54M | 7.55M | 5.31M | 5.1M | 5.84M | 5.98M | 5.55M | 4.25M | 3.49M | 5.2M | 4.89M | 4.6M | 4.18M | 4.48M | 3.88M |
Research & Development | 2.9M | 4.12M | 5.01M | 5.78M | 5.5M | 8.96M | 8.81M | 14.27M | 15.55M | 15.4M | 17.56M | 20.17M | 17.69M | 18.28M | 22.95M | 20.06M | 22.94M | 18.46M | 19.21M | 16.71M | 15.8M | 13.78M |
Other Expenses | 213K | n/a | -22K | n/a | 425K | 12.67M | -10.55M | 3.97M | 211K | 180K | -17.34M | 205K | -636K | 273K | -21.34M | 215K | 208K | 201K | -19.02M | 856K | -15.11M | -13.65M |
Operating Expenses | 6.98M | 10M | 8.68M | 8.81M | 9.25M | 27.46M | 6.7M | 22.78M | 23.31M | 20.9M | 5.33M | 26.22M | 23.04M | 24.1M | 5.86M | 23.76M | 28.35M | 23.56M | 4.79M | 21.75M | 5.17M | 4.01M |
Interest Expense | 18K | 17K | 18K | 23K | 28K | 28K | 30K | 29K | 34K | 44K | 44K | 46K | 171K | 198K | 309K | 429K | 482K | 506K | 560K | 762K | 763K | 772K |
Selling & Marketing Expenses | n/a | n/a | 11K | -11K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 6.98M | 10.01M | 8.7M | 8.82M | 9.25M | 36.42M | 15.51M | 22.78M | 23.31M | 20.9M | 22.89M | 26.22M | 23.04M | 24.1M | 28.81M | 23.76M | 28.35M | 23.56M | 24M | 21.75M | 20.97M | 17.79M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.44M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 197.47M | 193.77M | 191.6M | 191.78M | 191.55M | 190.71M | 185.61M | 189M | 188.04M | 175.63M | 168.44M | 167.51M | 166.06M | 161.64M | 154.42M | 151M | 148.75M | 143.32M | 101.29M | 101.02M | 96.87M | 93.43M |
Shares Outstanding (Diluted) | 197.47M | 195.21M | 191.6M | 191.78M | 192.4M | 190.71M | 189.96M | 189M | 188.04M | 175.63M | 168.44M | 167.51M | 166.06M | 161.64M | 154.42M | 151M | 148.75M | 148.43M | 101.29M | 101.29M | 96.87M | 93.43M |
EPS (Basic) | -0.03 | 0.88 | -0.02 | -0.04 | 0.01 | -0.13 | -0.07 | -0.10 | -0.11 | -0.10 | -0.11 | -0.12 | -0.10 | -0.10 | -0.15 | -0.11 | -0.10 | -0.11 | -0.21 | -0.19 | -0.20 | -0.18 |
EPS (Diluted) | -0.03 | 0.87 | -0.02 | -0.04 | 0.01 | -0.13 | -0.07 | -0.10 | -0.11 | -0.10 | -0.11 | -0.12 | -0.10 | -0.10 | -0.15 | -0.11 | -0.10 | -0.11 | -0.21 | -0.19 | -0.20 | -0.18 |
EBITDA | -5.11M | 169.72M | -3.73M | -7.71M | 2.56M | -24.17M | -15.34M | -19.35M | -19.41M | -17.48M | -20.16M | -19.69M | -16.58M | -15.81M | -20.65M | -16.8M | -13.33M | -10.42M | -20.18M | -17.95M | -17.51M | -15.1M |
EBIT | -5.13M | 169.71M | -3.74M | -7.72M | 2.55M | -24.5M | -15.67M | -19.69M | -19.76M | -17.83M | -20.52M | -20.06M | -16.92M | -16.14M | -20.95M | -17.14M | -13.71M | -10.82M | -20.6M | -18.4M | -17.95M | -15.55M |
Depreciation & Amortization | 11K | 11K | 11K | 11K | 11K | 333K | 333K | 336K | 356K | 355K | 359K | 369K | 342K | 334K | 307K | 343K | 383K | 394K | 427K | 447K | 436K | 443K |
Add to Watchlist
Select watchlists to add or remove ABUS